Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 28 02:39PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.15 Insider Own8.81% Shs Outstand30.79M Perf Week-1.35%
Market Cap90.21M Forward P/E- EPS next Y-1.10 Insider Trans0.85% Shs Float28.08M Perf Month7.72%
Income-29.25M PEG- EPS next Q-0.07 Inst Own17.99% Short Float / Ratio4.86% / 5.35 Perf Quarter-51.93%
Sales14.05M P/S6.42 EPS this Y9.60% Inst Trans8.01% Short Interest1.36M Perf Half Y-33.41%
Book/sh-0.07 P/B- EPS next Y-2.81% ROA-64.22% Target Price22.33 Perf Year-28.01%
Cash/sh0.93 P/C3.16 EPS next 5Y- ROE-428.87% 52W Range2.68 - 8.22 Perf YTD-24.09%
Dividend- P/FCF- EPS past 5Y- ROI-893.77% 52W High-64.36% Beta3.95
Dividend %- Quick Ratio0.90 Sales past 5Y154.89% Gross Margin93.36% 52W Low9.33% ATR0.16
Employees74 Current Ratio0.90 Sales Q/Q288.66% Oper. Margin-219.67% RSI (14)43.18 Volatility3.63% 4.84%
OptionableYes Debt/Eq- EPS Q/Q5.10% Profit Margin-208.16% Rel Volume0.20 Prev Close2.99
ShortableYes LT Debt/Eq- EarningsNov 14 AMC Payout- Avg Volume255.03K Price2.93
Recom1.00 SMA200.59% SMA50-13.74% SMA200-34.59% Volume40,358 Change-2.01%
Date Action Analyst Rating Change Price Target Change
Oct-26-22Initiated Ladenburg Thalmann Buy $15
Dec-26-18Downgrade Maxim Group Buy → Hold
Jan-26-18Reiterated H.C. Wainwright Buy $6.50 → $8.60
Sep-15-17Reiterated H.C. Wainwright Buy $2.15 → $6.50
Feb-13-17Resumed Rodman & Renshaw Buy $14
Jul-06-16Resumed H.C. Wainwright Buy $13
Jun-15-16Initiated ROTH Capital Buy
Nov-16-23 08:28AM
Nov-14-23 04:30PM
Nov-07-23 09:15AM
Nov-02-23 10:00AM
09:35AM Loading…
Oct-25-23 09:35AM
Oct-24-23 09:35AM
Oct-19-23 04:01PM
Oct-10-23 09:00AM
Sep-29-23 07:35AM
Sep-06-23 09:00AM
Aug-08-23 01:44PM
Aug-07-23 04:51PM
04:01PM Loading…
Aug-02-23 04:01PM
Jul-24-23 08:30AM
Jul-13-23 08:30AM
Jul-06-23 12:27PM
Jun-30-23 09:25AM
Jun-13-23 09:15AM
Jun-09-23 11:28AM
Jun-07-23 09:15AM
May-13-23 09:18AM
May-11-23 04:22PM
May-04-23 09:00AM
Apr-27-23 09:00AM
Mar-23-23 09:25AM
Mar-20-23 11:27AM
03:12AM Loading…
Mar-18-23 03:12AM
Mar-15-23 04:01PM
Mar-08-23 09:00AM
Mar-02-23 09:15AM
Feb-16-23 09:25AM
Jan-25-23 08:00AM
Jan-19-23 04:05PM
Jan-12-23 12:55PM
Jan-11-23 12:00PM
Dec-10-22 07:46AM
Nov-30-22 10:35AM
Nov-13-22 07:18AM
Nov-10-22 05:15PM
Nov-03-22 04:01PM
Oct-06-22 09:00AM
Sep-07-22 08:00AM
Aug-10-22 04:05PM
Aug-03-22 08:00AM
Jul-19-22 09:15AM
Jun-27-22 07:00AM
Jun-17-22 09:00AM
May-25-22 09:00AM
May-18-22 09:00AM
May-10-22 04:01PM
May-03-22 08:30AM
May-02-22 10:08AM
Mar-29-22 09:00AM
Mar-28-22 12:06PM
Mar-11-22 08:00AM
Mar-10-22 04:01PM
Mar-03-22 09:15AM
Mar-02-22 09:00AM
Feb-15-22 06:27AM
Jan-25-22 02:58PM
Dec-30-21 07:57AM
Dec-13-21 09:15AM
Nov-19-21 10:00AM
Nov-17-21 05:24AM
Nov-12-21 09:15AM
Nov-09-21 06:45PM
Nov-03-21 07:30AM
Nov-02-21 04:05PM
Sep-24-21 09:28AM
Sep-22-21 04:05PM
Sep-07-21 09:00AM
Sep-02-21 08:30AM
Aug-19-21 09:45AM
Aug-12-21 04:01PM
Aug-05-21 09:00AM
Jul-27-21 08:00AM
Jun-23-21 08:27AM
Jun-17-21 09:00AM
Jun-13-21 02:37PM
Jun-10-21 09:15AM
May-18-21 08:30AM
May-13-21 04:05PM
May-12-21 09:00AM
May-06-21 08:30AM
Apr-29-21 08:00AM
Mar-13-21 01:28AM
Mar-11-21 04:01PM
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bergmann AnthonyCHIEF FINANCIAL OFFICEROct 23Option Exercise1.392,1783,0272,381Oct 24 09:25 AM
Musket David BDirectorOct 12Buy2.754101,12831,536Oct 13 01:59 PM
COLLIER EARL M JRDirectorOct 10Buy2.8310,00028,30026,856Oct 12 09:15 AM
Musket David BDirectorOct 09Buy2.825,08314,33431,126Oct 11 09:15 AM
Auwaerter Paul GisbertDirectorOct 06Buy2.845,00014,2005,000Oct 10 09:15 AM
Musket David BDirectorOct 04Buy2.902,5007,25026,043Oct 06 09:15 AM
Litvack FrankDirectorAug 14Option Exercise1.3920,74828,840137,633Aug 16 05:00 PM
Marban LindaCHIEF EXECUTIVE OFFICERMay 12Option Exercise1.3920,74928,841198,604May 16 07:00 PM
Avat XavierFormer CBOApr 17Sale4.3514,77264,2580Apr 27 05:28 PM
Avat XavierFORMER CHIEF BUSINESS OFFICERApr 05Option Exercise3.4684,791293,37784,791Apr 07 05:00 PM
Avat XavierFORMER CHIEF BUSINESS OFFICERMar 28Sale4.063,00012,1800Apr 07 05:00 PM
Litvack FrankDirectorFeb 21Option Exercise1.3914,02719,498141,800Feb 23 09:00 AM
Manzo LouisDirectorFeb 21Option Exercise1.391,4011,94762,599Feb 23 09:00 AM
COLLIER EARL M JRDirectorFeb 14Option Exercise1.391,4011,94716,856Feb 15 08:00 PM
DUNBAR GEORGE W JRDirectorFeb 14Option Exercise1.391,4011,94710,556Feb 15 08:00 PM